Literature DB >> 2130569

Assessment of myocardial perfusion and viability with technetium-99m methoxyisobutyl isonitrile.

G A Beller1, A J Sinusas, D D Watson.   

Abstract

The clinical application of Tc-99m Sestamibi imaging in acute myocardial infarction should be most useful. The capability of assessing risk area during acute coronary occlusion and degree of myocardial salvage after reperfusion offers a noninvasive means to assess the benefit of therapeutic interventions aimed at reducing myocardial ischemic injury. Further studies in larger numbers of patients appear warranted to identify the precise worth of this new imaging technique relative to other existing noninvasive imaging methodologies in clinical practice.

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 2130569      PMCID： PMC2376650     

Source DB:  PubMed          Journal:  Trans Am Clin Climatol Assoc        ISSN： 0065-7778


  8 in total

1.  Quantification of area at risk during coronary occlusion and degree of myocardial salvage after reperfusion with technetium-99m methoxyisobutyl isonitrile.

Authors:  A J Sinusas; K A Trautman; J D Bergin; D D Watson; M Ruiz; W H Smith; G A Beller
Journal:  Circulation       Date:  1990-10       Impact factor: 29.690

2.  Myocardial kinetics of technetium-99m-hexakis-2-methoxy-2-methylpropyl-isonitrile.

Authors:  R D Okada; D Glover; T Gaffney; S Williams
Journal:  Circulation       Date:  1988-02       Impact factor: 29.690

3.  Effect of ischemia and postischemic dysfunction on myocardial uptake of technetium-99m-labeled methoxyisobutyl isonitrile and thallium-201.

Authors:  A J Sinusas; D D Watson; J M Cannon; G A Beller
Journal:  J Am Coll Cardiol       Date:  1989-12       Impact factor: 24.094

4.  Serial quantitative planar technetium-99m isonitrile imaging in acute myocardial infarction: efficacy for noninvasive assessment of thrombolytic therapy.

Authors:  F J Wackers; R J Gibbons; M S Verani; D S Kayden; P A Pellikka; T Behrenbeck; J J Mahmarian; B L Zaret
Journal:  J Am Coll Cardiol       Date:  1989-10       Impact factor: 24.094

5.  Feasibility of tomographic 99mTc-hexakis-2-methoxy-2-methylpropyl-isonitrile imaging for the assessment of myocardial area at risk and the effect of treatment in acute myocardial infarction.

Authors:  R J Gibbons; M S Verani; T Behrenbeck; P A Pellikka; M K O'Connor; J J Mahmarian; J H Chesebro; F J Wackers
Journal:  Circulation       Date:  1989-11       Impact factor: 29.690

6.  Coronary artery reperfusion in acute myocardial infarction: assessment by pre- and postintervention thallium-201 myocardial perfusion imaging.

Authors:  P M De Coster; J A Melin; J M Detry; L A Brasseur; C Beckers; J Col
Journal:  Am J Cardiol       Date:  1985-04-01       Impact factor: 2.778

7.  Coronary artery reperfusion in acute myocardial infarction: beneficial effects of intracoronary streptokinase on left ventricular salvage and performance.

Authors:  L A Reduto; G C Freund; J M Gaeta; R W Smalling; B Lewis; K L Gould
Journal:  Am Heart J       Date:  1981-12       Impact factor: 4.749

8.  Technetium-99m hexakis 2-methoxyisobutyl isonitrile: human biodistribution, dosimetry, safety, and preliminary comparison to thallium-201 for myocardial perfusion imaging.

Authors:  F J Wackers; D S Berman; J Maddahi; D D Watson; G A Beller; H W Strauss; C A Boucher; M Picard; B L Holman; R Fridrich
Journal:  J Nucl Med       Date:  1989-03       Impact factor: 10.057
  8 in total
  1 in total

1.  Kinetic characterization of a novel cationic (99m)Tc(I)-tricarbonyl complex, (99m)Tc-15C5-PNP, for myocardial perfusion imaging.

Authors:  Zhonglin Liu; Liying Chen; Shuang Liu; Christy Barber; Gail D Stevenson; Lars R Furenlid; Harrison H Barrett; James M Woolfenden
Journal:  J Nucl Cardiol       Date:  2010-07-29       Impact factor: 5.952
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.